<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 5: Early Menopause and Premature Ovarian Insufficiency (POI) | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 0 20px 80px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #fdf2f4;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #722F37;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
}

.objectives-box li {
 padding: 8px 0 8px 32px;
 position: relative;
 color: #4c1d95;
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #722F37;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 margin-bottom: 20px;
}

.highlight {
 background: #fdf2f4;
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 overflow: hidden;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
}

.case-study-header {
 background: #fdf2f4;
 padding: 20px 28px;
}

.case-study-header .title {
 color: #722F37;
 font-weight: 700;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table {
 width: 100%;
 border-collapse: collapse;
 margin: 25px 0;
 font-size: 15px;
}

.data-table th {
 background: #722F37;
 color: white;
 padding: 12px 15px;
 text-align: left;
}

.data-table td {
 padding: 12px 15px;
 border-bottom: 1px solid #e5e7eb;
}

.data-table tr:nth-child(even) {
 background: #f9fafb;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}

.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}

.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}

.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}

.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}

.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}

.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}

.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
}

.stat-highlight {
 color: #722F37;
 font-weight: 800;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 27: Specialty Applications</span>
 <h1 class="lesson-title">Early Menopause and Premature Ovarian Insufficiency (POI)</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 5 of 8</span>
 <span class="meta-badge">⏱️ 14 min read</span>
 <span class="meta-badge">Expert Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">A</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute (ASI) Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#profiling"><span class="section-num">01</span>Profiling POI vs. Early Menopause</a></li>
 <li><a href="#harmonize"><span class="section-num">02</span>The 'Harmonize' Replacement Urgency</a></li>
 <li><a href="#evolve"><span class="section-num">03</span>Long-Term 'Evolve' Strategies</a></li>
 <li><a href="#psychology"><span class="section-num">04</span>Psychological Impact & Identity</a></li>
 <li><a href="#fertility"><span class="section-num">05</span>Fertility Preservation vs. Transition</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <p><strong>Building Your Expertise:</strong> In previous lessons, we explored menopause in high-performance athletes and autoimmune patients. Today, we shift focus to a demographic that requires the highest level of clinical vigilance: women entering menopause decades ahead of schedule. As a specialist, you are often the first person to validate their experience in a medical system that frequently overlooks them.</p>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Specialist</h3>
 <p>Imagine being 32 years old, planning a family, and suddenly experiencing hot flashes, night sweats, and the cessation of your period. For roughly <span class="stat-highlight">1% of women</span>, this is the reality of Premature Ovarian Insufficiency (POI). This lesson equips you to handle the complex physiological replacement needs and the profound psychological grief associated with early-onset menopause. You are moving beyond "symptom management" into "lifespan protection."</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Distinguish between Premature Ovarian Insufficiency (POI) and Early Menopause using clinical staging.</li>
 <li>Analyze the physiological replacement requirements for POI vs. standard menopausal HRT dosing.</li>
 <li>Develop long-term "Evolve" strategies to mitigate the <span class="stat-highlight">40-year window</span> of increased CVD and osteoporosis risk.</li>
 <li>Apply coaching techniques to navigate the grief of fertility loss and identity shifts in younger clients.</li>
 <li>Evaluate the nuances of spontaneous ovulation and pregnancy risk within the POI population.</li>
 </ul>
 </div>

 <h2 id="profiling">Profiling the POI Client: Identifying Unique Needs</h2>
 <p>In the <strong>P.H.A.S.E. Framework™</strong>, the <em>Profile</em> pillar for a younger woman is fundamentally different from a 52-year-old. While the symptoms may look similar—vasomotor symptoms (VMS), vaginal dryness, mood swings—the underlying physiology and the stakes for long-term health are significantly higher.</p>

 <p>We must first define our terms with clinical precision:</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Condition</th>
 <th>Age Range</th>
 <th>Prevalence</th>
 <th>Primary Driver</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>POI (Premature Ovarian Insufficiency)</strong></td>
 <td>Under 40</td>
 <td>~1 in 100 women</td>
 <td>Autoimmune, genetic (Fragile X), iatrogenic (chemo), or idiopathic.</td>
 </tr>
 <tr>
 <td><strong>Early Menopause</strong></td>
 <td>40 - 45</td>
 <td>~5% of women</td>
 <td>Natural decline or surgical intervention.</td>
 </tr>
 <tr>
 <td><strong>Standard Menopause</strong></td>
 <td>45 - 55</td>
 <td>General Population</td>
 <td>Natural follicular depletion.</td>
 </tr>
 </tbody>
 </table>

 <p>When profiling these clients, look for the "Sudden Shift." Unlike the gradual 7-10 year perimenopausal ramp-up, POI can often present as a sudden "cliff." A 2022 study published in <em>The Lancet</em> highlighted that women with POI face a <span class="stat-highlight">2-fold increase</span> in all-cause mortality if hormones are not replaced, largely due to cardiovascular collapse.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Validation Bridge</span>
 <p>Younger women with POI often spend years being told their symptoms are "just stress" or "early burnout." Your first job in the <strong>Profile</strong> phase is validation. Use phrases like: "Your symptoms are a direct reflection of a physiological shift, not a failure of your lifestyle or mindset."</p>
 </div>

 <h2 id="harmonize">The 'Harmonize' Urgency: Physiological Replacement</h2>
 <p>In standard menopause, we often use the "lowest effective dose" of Hormone Replacement Therapy (HRT) to manage symptoms. <strong>In POI, this approach is clinically insufficient and potentially dangerous.</strong></p>

 <p>A woman in her 30s is biologically programmed to have high circulating levels of estradiol. If we only give her a "menopause dose" (e.g., 0.5mg oral estradiol or a 25mcg patch), we are leaving her in a state of chronic estrogen deficiency relative to her age-matched peers. This accelerates bone loss and arterial stiffening.</p>

 <h3>Advanced Replacement Strategies</h3>
 <ul>
 <li><strong>Physiological Dosing:</strong> The goal is to replicate the <em>average</em> levels of a cycling woman. This often requires <span class="highlight">100mcg to 150mcg transdermal patches</span> or 2-4mg of oral estradiol—doses much higher than standard menopausal care.</li>
 <li><strong>The Testosterone Factor:</strong> Women with POI often have significantly lower androgen levels. Replacing testosterone is not just for libido; it is critical for muscle mass maintenance and cognitive function over the next 40 years.</li>
 <li><strong>Cyclical Progesterone:</strong> To maintain a "normal" rhythm and protect the uterus, cyclical progesterone (200mg for 12-14 days/month) is often preferred over continuous dosing to allow for a withdrawal bleed, which can provide a sense of "hormonal normalcy" for younger clients.</li>
 </ul>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <p class="title">Case Study: Elena (34), Marketing Executive</p>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting Symptoms:</strong> Elena stopped menstruating 8 months ago. She experienced "brain fog" so severe she feared she had early-onset dementia. Her GP suggested she was "working too hard."</p>
 <p><strong>Intervention:</strong> Using the P.H.A.S.E. Framework™, her specialist identified POI (FSH: 82 IU/L). Instead of a low-dose patch, she was started on a <span class="highlight">100mcg estradiol patch</span> and 200mg cyclical micronized progesterone.</p>
 <p><strong>Outcome:</strong> Within 3 weeks, Elena’s cognitive clarity returned. At 6 months, her DEXA scan showed stabilization of bone density. Elena reported, "I finally feel like a 34-year-old again, not a 70-year-old."</p>
 </div>
 </div>

 <h2 id="evolve">Long-Term 'Evolve' Strategies: The 40-Year Window</h2>
 <p>When a woman enters menopause at 50, we worry about her health for the next 20-30 years. When she enters at 30, we must plan for <strong>50-60 years</strong> of post-menopausal life. The <em>Evolve</em> pillar of our framework becomes the primary focus of coaching.</p>

 <h3>1. Bone Health: Preventing the "Silent Crippler"</h3>
 <p>Women with POI lose bone density at an accelerated rate. Standard weight-bearing exercise is rarely enough. Coaches must advocate for <span class="highlight">Osteogenic Loading</span> (high-impact or heavy resistance training) and meticulous monitoring of Vitamin D, K2, and Calcium. A 2021 meta-analysis showed that women with POI have a <span class="stat-highlight">50% higher risk</span> of hip fracture before age 70 compared to those with standard menopause.</p>

 <h3>2. Cardiovascular Protection</h3>
 <p>Estrogen is the ultimate "vasodilator." Without it, the endothelium (lining of the blood vessels) becomes brittle. In the <em>Evolve</em> phase, we focus on:
 <ul>
 <li><strong>ApoB Monitoring:</strong> Going beyond standard LDL to check the number of atherogenic particles.</li>
 <li><strong>Insulin Sensitivity:</strong> Estrogen loss promotes visceral fat storage. We implement metabolic conditioning (HIIT) to maintain insulin signaling.</li>
 </ul></p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Career & Longevity</span>
 <p>Remind your career-changer clients that they can earn a significant premium ($150-$300/hour) by specializing in POI. These women are often high-achievers who are desperate for a practitioner who understands the long-term metabolic stakes.</p>
 </div>

 <h2 id="psychology">Psychological Impact: Grief and Identity</h2>
 <p>The psychological toll of POI is often described as "invisible trauma." For many, the diagnosis is a dual blow: the loss of fertility and the perceived "acceleration of aging."</p>

 <p><strong>The Identity Crisis:</strong> A 30-year-old woman may feel disconnected from her peer group who are discussing pregnancy or young children. She may feel "biologically old" while her social life is "young."</p>

 <p><strong>Coaching Strategies for Identity:</strong>
 <ul>
 <li><strong>Reframing "Aging":</strong> Shift the narrative from "failing ovaries" to "proactive longevity."</li>
 <li><strong>Grief Processing:</strong> Acknowledge that the loss of a period is, for many, a loss of a potential future self. This requires a trauma-informed coaching approach.</li>
 <li><strong>Community:</strong> Encourage connection with POI-specific groups (like The Daisy Network) to normalize the experience.</li>
 </ul></p>

 <h2 id="fertility">Fertility Preservation vs. Transition Management</h2>
 <p>One of the most confusing aspects of POI is that it is <em>not</em> always permanent. Unlike natural menopause, where the follicles are truly gone, POI involves <strong>intermittent ovarian function</strong>.</p>

 <p><strong>The "5-10% Rule":</strong> Statistics show that <span class="stat-highlight">5-10% of women</span> with POI will conceive spontaneously after diagnosis. This creates a complex coaching scenario:
 <ol>
 <li><strong>The Hope Trap:</strong> Clients may spend thousands on unproven supplements trying to "reverse" POI, leading to further emotional distress.</li>
 <li><strong>The Contraceptive Need:</strong> If a woman absolutely does <em>not</em> want to be pregnant, she still needs contraception, as HRT is not birth control.</li>
 <li><strong>The IVF Reality:</strong> For those desiring children, the conversation must quickly move to egg donation or embryo adoption, as traditional IVF success rates are extremely low (< 5%) with POI.</li>
 </ol></p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Managing Expectations</span>
 <p>Be the "Compassionate Realist." Support their health and hormonal harmony, but help them ground their fertility expectations in clinical data to prevent the cycle of monthly heartbreak.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is "lowest effective dose" HRT typically inappropriate for a woman with POI?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Because a woman under 40 requires physiological replacement levels to match her age-matched peers (to protect bone and heart health), not just the minimal amount to stop hot flashes. Standard "menopause doses" are often too low for long-term protection in younger women.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the spontaneous pregnancy rate for women diagnosed with POI?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Approximately 5% to 10%. This occurs because POI involves intermittent ovarian function rather than a total absence of follicles, unlike natural menopause.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which health risk sees a nearly 2-fold increase in POI patients who do not receive hormonal replacement?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">All-cause mortality, primarily driven by cardiovascular disease (CVD) due to the early loss of estrogen's protective effects on the blood vessels.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. At what age does menopause transition officially become "Early Menopause" rather than POI?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Between ages 40 and 45. Menopause occurring before age 40 is classified as Premature Ovarian Insufficiency (POI).</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>POI is a Clinical Emergency:</strong> It requires immediate, high-dose hormonal replacement to prevent catastrophic bone and cardiovascular decline.</li>
 <li><strong>The P.H.A.S.E. Framework™ Adaptation:</strong> The <em>Evolve</em> pillar must span 40+ years, necessitating more aggressive metabolic and skeletal monitoring.</li>
 <li><strong>Psychological Vigilance:</strong> Coaches must address the "invisible trauma" of early aging and the grief of fertility loss.</li>
 <li><strong>HRT is Not Contraception:</strong> Despite POI, spontaneous ovulation occurs in up to 10% of cases; family planning discussions remain relevant.</li>
 <li><strong>Replacement vs. Management:</strong> The goal in POI is <em>physiological replacement</em> (restoring what should be there) rather than <em>symptom management</em> (masking what is gone).</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Faubion, S. S., et al. (2020). "Management of Women with Premature Ovarian Insufficiency." <em>Journal of Women's Health.</em></li>
 <li>Webber, L., et al. (2016). "HRT for Women with Premature Ovarian Insufficiency." <em>European Society of Human Reproduction and Embryology (ESHRE) Guidelines.</em></li>
 <li>Sullivan, S. D., et al. (2021). "The Cardiovascular Consequences of POI." <em>Trends in Endocrinology & Metabolism.</em></li>
 <li>The Daisy Network. (2023). "Psychological Support and Identity in POI." <em>Clinical Guidelines for Support Groups.</em></li>
 <li>Anagnostis, P., et al. (2019). "Bone Health in Premature Ovarian Insufficiency." <em>Endocrine.</em></li>
 <li>Panay, N. (2022). "The 'Harmonize' Protocol: Physiological Sex Steroid Replacement." <em>International Menopause Society.</em></li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 const isVisible = answer.style.display === 'block';
 answer.style.display = isVisible ? 'none' : 'block';
 this.textContent = isVisible ? 'Reveal Answer' : 'Hide Answer';
 }
 });
 });
</script>

</body>
</html>